Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81
Document › Details

Bone Therapeutics S.A.. (3/7/18). "Press Release: Bone Therapeutics Successfully Raises EUR 19.45 Million of Commitments in Convertible Bond Placement [Not for the United States, Australia, Canada, Japan, South Africa, et al.]". Gosselies.

Organisations Organisation Bone Therapeutics S.A. (Euronext Brussels + Paris: BOTHE)
  Group Bone Therapeutics (Group)
  Organisation 2 NewCap. – Investor Relations & Financial Communications
Products Product ALLOB® allogeneic bone cell product
  Product 2 investment banking
Persons Person Lienard, Thomas (Bone Therapeutics 201610– Interim CEO joined 201511– as CBO before Lundbeck + Lilly + McKinsey)
  Person 2 Laurent, Pierre (NewCap. 201404 CEO + Owner)

Record changed: 2018-03-22


Picture ConsulTech GmbH RnD Credit Germany 650x80px

More documents for Bone Therapeutics (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80

» top